CIGB-300 (P15-Tat)
Anti-CK2 cyclic cell-penetrating research peptide.
Oncology Research Peptides
Tyroservatide (YSV) is a synthetic tripeptide studied as a low-molecular-weight antitumor research reagent across hepatocellular-carcinoma, non-small-cell-lung-cancer, ovarian-carcinoma, colon-carcinoma, and melanoma cell-line research. Research applications include anti-metastasis and invasion-suppression studies, MMP-2/MMP-9 and integrin–FAK signaling research, and multidrug-resistance (MDR) reversal research in resistant hepatocellular-carcinoma cell-line models.
Research Use Only · Buyer verification required
Specifications
Documentation & Quality
Documentation is lot-specific. The statuses above describe what may be available, not a specific batch result. Lot-specific documentation is available with quotation or order. Please contact our team to confirm current documentation availability.
Request a QuoteRequest a Quote
Bulk quantities, custom purity, documentation, and packaging options are reviewed for qualified business buyers.
Anti-CK2 cyclic cell-penetrating research peptide.
Telomerase-derived 16-mer research peptide.
PSP-94-derived antitumor research peptide.